A novel terpenoid class for prevention and treatment of KRAS-driven cancers: Comprehensive analysis using in situ, in vitro, and in vivo model systems.

Saved in:
Bibliographic Details
Title: A novel terpenoid class for prevention and treatment of KRAS-driven cancers: Comprehensive analysis using in situ, in vitro, and in vivo model systems.
Authors: Ganaie AA; Department of Urology, Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota., Siddique HR; Department of Urology, Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota.; Department of Zoology, Aligarh Muslim University, Aligarh, Uttar Pradesh, India., Sheikh IA; King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia., Parray A; Department of Urology, Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota.; Academic Health Systems Hamad Medical Corporation, Doha, Qatar., Wang L; Hormel Institute, University of Minnesota, Austin, Minnesota., Panyam J; School of Pharmacy, University of Minnesota, Minneapolis, Minnesota., Villalta PW; Analytical Chemistry Core, Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota., Deng Y; Department of Urology, Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota., Konety BR; Department of Urology, Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota., Saleem M; Department of Urology, Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota.
Source: Molecular carcinogenesis [Mol Carcinog] 2020 Aug; Vol. 59 (8), pp. 886-896. Date of Electronic Publication: 2020 Apr 15.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 8811105 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-2744 (Electronic) Linking ISSN: 08991987 NLM ISO Abbreviation: Mol Carcinog Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Be the first to leave a comment!
You must be logged in first